Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

The Prostate Health Education Network launched a new online portal focused on precision medicine care for prostate cancer ...

Such anxieties are all the more acute when it comes to highly sensitive personal information, such as genetic data, which not only affects one individual but all their relatives, too. When you spit ...

raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne Wojcicki has said she intends to take the company private and is not ...

There is no cure, and limited treatment options are currently available. The International Alliance of ALS/MND Associations ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.

Harriet Harrison has used a cold cap to help her keep her hair during chemotherapy treatment (Image: The Clatterbridge Cancer Centre NHS Foundation Trust) After diagnosis, Harriet went through 'lots ...